關於 nasdaq ntla ，我們在網路上蒐集到這些相關的討論、資訊與評價

#11. Intellia Therapeutics, Inc Financial Statements – NASDAQ:NTLA

Get a brief overview of Intellia Therapeutics, Inc financials with all the important numbers. View the latest NTLA income statement, balance sheet, ...

#12. Intellia Therapeutics (NTLA) Stock Forecast & Price Target

Based on 15 Wall Street analysts offering 12 month price targets for Intellia Therapeutics in the last 3 months. The average price target is $79.92 with a high ...

#13. Intellia Therapeutics Inc (NASDAQ:NTLA) Share Price

Real-time share price updates and latest news for Intellia Therapeutics Inc (NASDAQ:NTLA). Compare across sectors, industries & regions.

#14. Intellia stock gains after gene editing data (NASDAQ:NTLA)

Intellia Therapeutics (NASDAQ:NTLA) added ~5% pre-market Monday after announcing new data from its Phase 1/2 trial for its gene editing ...

#15. NTLA Stock Options Chain, Prices and News - Webull

Webull offers NTLA Ent Holdg (NTLA) historical stock prices, in-depth market analysis, NASDAQ: NTLA real-time stock quote data, in-depth charts, free NTLA ...

#16. NTLA(NTLA)股票股价,实时行情,新闻,财报,研报评级_新浪财经

新浪财经-美股频道为您提供NTLA(NTLA)股票股价,股票实时行情,新闻,财报,美股实时交易数据,研究报告,评级,财务指标分析等 ... NTLA NASDAQ:NTLA Intellia Therapeutic.

#17. Intellia Therapeutics (NTLA) Stock Forecast, Price & News

About Intellia Therapeutics (NASDAQ:NTLA) Stock. Intellia Therapeutics, Inc. is a clinical stage genome editing company, which engages in the development of ...

#18. NTLA: Intellia Therapeutics Inc - Stock Price, Quote and News

Get Intellia Therapeutics Inc (NTLA:NASDAQ) real-time stock quotes, news, price and financial information from CNBC.

#19. Intellia Therapeutics (NASDAQ:NTLA) Stock Price News

Is Intellia Therapeutics (NASDAQ:NTLA) a buy? Compare the latest price, visualised quantitative ratios, annual reports, historical dividends, ...

#20. Intellia Therapeutics(NTLA) Stock Price,News,Quote-Futubull

Provide the latest Intellia Therapeutics(NTLA) market data, ... Intellia Therapeutics (NASDAQ:NTLA) has observed the following analyst ratings within the ...

#21. Intellia Therapeutics - investor relations

NASDAQ | NTLA (Common Stock). $43.61 0 (0.00%). Stock Chart. Data Provided by Refinitiv. Minimum 15 minutes delayed. Press Releases. Jun 11, 2023.

#22. NTLA: Intellia Therapeutics Inc Stock Price Quote - NASDAQ GM

Stock analysis for Intellia Therapeutics Inc (NTLA:NASDAQ GM) including stock price, stock chart, company news, key statistics, fundamentals and company ...

#23. Intellia Therapeutics Inc. (NTLA) - Stocks - Value Research

Get Intellia Therapeutics Inc. (NTLA)'s stock analysis, price valuation, ... Key Ratios; Peer Comparison; Financials; Share Holdings; Other details. NASDAQ ...

#24. NTLA - Intellia Thera CS Stock Price - Barchart.com

Intellia Thera CS (NTLA) ... 43.24 -0.12 (-0.28%) 06/09/23 [NASDAQ] ... Why Intellia Therapeutics, Inc. (NTLA) is a Great Choice Zacks - Tue May 9, ...

#25. NTLA | Intellia Therapeutics Inc. Annual Balance Sheet - WSJ

Compare to Benchmark: DJIA; S&P 500; GLOBAL DOW; NASDAQ; Health Care/Life Sciences. Compare to; Add. Open 44.61; Prior Close 43.36 (06/08/23). 1 Day; NTLA ...

#26. Intellia Therapeutics Stock (NASDAQ:NTLA), Quotes and ...

Intellia Therapeutics Stock (NASDAQ: NTLA) stock price, news, charts, stock research, profile.

#27. NASDAQ: NTLA Intellia Therapeutics Inc Stock - WallStreetZen

NTLA ($43.24) is undervalued by 13.18% relative to our estimate of its Fair Value price of $49.81 based on Discounted Cash Flow (DCF) modelling, ...

#28. NTLA Institutional Ownership and Shareholders - Intellia ...

File Date Source Shares Shares Changed (%) Reported Value ($1000) Value Change... 2022‑12‑21 NP 30,288 ‑16.74 1,599 ‑32.14 2022‑12‑21 NP 2,720 0.00 144 ‑18.75 2022‑12‑21 NP 987,000 0.00 52,094 ‑18.50

#29. NTLA Stock | INTELLIA THERAPEUTICS Stock Price Today

NTLA : Get the latest Intellia Therapeutics stock price and detailed ... based on an analysis of the firm's balance sheet and inputs from the stock market.

#30. NTLA Stock Quote | Volume Chart Intellia Therapeutics

NTLA Stock Summary and Trading Ideas (Intellia Therapeutics | NASDAQ:NTLA) · Trade Ideas for Best Option Strategies for NTLA by Theoretical Edge and Win Rates.

#31. Intellia Therapeutics, Inc. (NTLA) Stock Price, Quote & News

According to 18 analysts, the average rating for NTLA stock is "Buy." The 12-month stock price forecast is $75.65, which is an increase of 74.95% from the ...

#32. Intellia Therapeutics Inc (NTLA) | Finance information

NTLA. $43.61. -16.6% last 12 months. 1Y3Y5Y15Y ... Sunday, Intellia Therapeutics Inc (NASDAQ: NTLA ) announced updated interim results from the Phase 1 ...

#33. NTLA Intellia Therapeutics Inc - StockTwits

$NTLA has a Quick Ratio of 9.32, indicating it is financially healthy. chartmill.com/stock/quote/N... Fundamental Analysis of INTELLIA THERAPEUTICS INC(NASDAQ: ...

#34. NTLA - Intellia Therapeutics Inc Forecast - CNNMoney.com

Intellia Therapeutics Inc (NASDAQ:NTLA). 46.05. Delayed Data. As of 3:59pm ET. +2.44 / +5.60%. Today's Change. 32.44. Today|||52-Week Range. 76.45. +31.99%.

#35. Intellia Therapeutics - Wikipedia

Nasdaq : NTLA · Russell 2000 Component · Biotherapeutics · 2014 · Cambridge, MA. ,. United States · John Leonard (President & CEO); Glenn Goddard (CFO); David ...

#36. NTLA - Intellia Therapeutics Inc - 市場| 美股| Anue鉅亨 - 基金

鉅亨美股頻道提供你最完整的NTLA - Intellia Therapeutics Inc 、美股公司資料、美股股票代號、美股新聞、股價走勢、技術線圖、財報分析、外資分析師評等、歷史股價、 ...

#37. intellia therapeutics inc (nasdaq: ntla) - InvestingNote

Investing ideas, stock information, fundamental analysis, technical analysis on INTELLIA THERAPEUTICS INC ($NTLA) from SE Asia's most active stock investing ...

#38. Intellia Therapeutics Announces First Quarter 2023

(NASDAQ:NTLA), a leading clinical-stage genome editing company focused on developing potentially curative therapies leveraging CRISPR-based ...

#39. Intellia Therapeutics Inc, NTLA:NMQ summary - FT.com

Select symbol · United States · NTLA:NMQNASDAQ · Germany · 38I:DEUGerman Composite · 38I:STUStuttgart Stock Exchange · 38I:FRAFrankfurt Stock Exchange · 38I:BERBerlin ...

#40. Intellia Therapeutics and CRISPR Therapeutics Announce ...

(NASDAQ:NTLA) and CRISPR Therapeutics AG (NASDAQ:CRSP), two leading genome editing companies focused on the development of potentially curative therapies, ...

#41. Intellia Therapeutics Inc (NASDAQ: NTLA) - Bazaartrend

NTLA STOCK Price - Intellia Therapeutics Inc NASDAQ USA Technical Analysis, Forecast, Important Levels, Latest News, Interactive Charts.

#42. Intellia Therapeutics Inc (NTLA) - Markets | IEX Cloud

Largest trades ; 6,000, 45.26, Off Exchange, 06:51:30 ; 5,477, 45.49, Nasdaq, 08:18:11.

#43. Vertex, Intellia Therapeutics: Gene Editing Stocks To Watch

Within our theme, Intellia Therapeutics (NASDAQ: NTLA) has been the strongest performer year-to-date, rising by around 35% since early ...

#44. NTLA-Intellia Therapeutics, Inc.-基本資料-美股-MoneyDJ理財網

英文名稱, Intellia Therapeutics, Inc. 交易代號, NTLA. 中文名稱, 交易所, Nasdaq. 地址, 40 Erie Street,Cambridge,Massachusetts 02139,United States Of America ...

#45. NTLA Stock Price & Charts | Intellia Therapeutics - YCharts

Intellia Therapeutics Inc (NTLA). 43.67 +2.40 (+5.82%) USD | NASDAQ | Jun ...

#46. Intellia Therapeutics Announces Third Quarter 2022 Financial ...

(NASDAQ:NTLA), a leading clinical-stage genome editing company focused on developing potentially curative therapies leveraging CRISPR-based ...

#47. NTLA Stock Rises On Potential CRISPR Cure For Swelling ...

On today's stock market, NTLA stock rose 0.9% to close at 43.61, paring back bigger gains. That briefly helped prop up shares of other ...

#48. Intellia Therapeutics Inc. (NTLA) Share Price

Intellia Therapeutics Inc. (NTLA) Share Price and News. Using CRISPR/Cas9 technology, ... NASDAQ. Price. 43.24 USD. Day Change. -0.28%. Market Cap:.

#49. Intellia Therapeutics Inc (NTLA) 財報分析和股票健診

公司簡介. 交易所： 那斯達克. 公司產業： Medical. 公司網址： https://www.

#50. Intellia and Regeneron Announce Updated Phase 1 Data ...

Intellia Therapeutics, Inc. (NASDAQ: NTLA) and Regeneron Pharmaceuticals, Inc. (NASDAQ: REGN) today announced positive interim data from an ...

#51. INTELLIA THERAPEUTICS, INC. - NTLA - Market Screener

INTELLIA THERAPEUTICS, INC. : News, information and stories for INTELLIA THERAPEUTICS, INC. | Nasdaq: NTLA | Nasdaq.

#52. Pomerantz Law Firm Investigates Claims On Behalf of ... - KKCO

("Intellia" or the "Company") (NASDAQ: NTLA). Such investors are advised to contact Robert S. Willoughby at [email protected] or 888-476-6529 ...

#53. EDGAR Entity Landing Page - SEC.gov

Intellia Therapeutics, Inc. NTLA on Nasdaq. This company's Exchange Act registration has been revoked. This company's Exchange Act registration as a ...

#54. 3 High-Growth Biotech Stocks Poised for Success in 2023

The mid-cap stock on this list is Intellia Therapeutics (NASDAQ:NTLA). Like Vertex, Intellia is trying to bring a drug to market based on ...

#55. CMN Markets February 2022 | CRISPR Stocks and Market News

While the global stock market initially took a substantial downturn (Figure 1), ... On February 28 th Intellia Therapeutics (NASDAQ: NTLA) announced updated ...

#56. How to buy Intellia Therapeutics stock - (NASDAQ - Finder.com

#57. NTLA - Intellia Therapeutics, Inc. Stock Price and Quote

Investors push Intellia Therapeutics (NASDAQ:NTLA) 3.5% lower this week, company's increasing losses might be to blame. (Simply Wall St.) Mar-29-23 04:20PM.

#58. Sapna Srivastava, PhD - Nuvalent Investors

(NASDAQ: NTLA), a gene editing company. Previously, for nearly 15 years Dr. Srivastava was a senior biotechnology analyst at Goldman Sachs, Morgan Stanley, and ...

#59. Invest in Intellia Therapeutics Inc.NTLA from Anywhere | Stockal

Shares of Intellia Therapeutics, Inc. (NASDAQ:NTLA Get Rating) have received a consensus recommendation of Moderate Buy from the nineteen research firms that ...

#60. Intellia Therapeutics Announces New Positive Clinical Data ...

(NASDAQ:NTLA), a leading clinical-stage genome editing company focused on developing potentially curative therapeutics leveraging CRISPR-based ...

#61. NTLA Stock Price - Intellia Therapeutics, Inc. - Disfold

Official Company Name: Intellia Therapeutics, Inc. Stock Symbol: NTLA. Stock Market: NASDAQ Global Market - NASDAQ. Currency: United States dollar - USD.

#62. SVB Leerink Trims Intellia Therapeutics (NASDAQ:NTLA ...

IntelliaTherapeutics (NASDAQ:NTLA – Get Rating) had its price objective trimmed by SVB Leerink from $90.00 to $86.00 in a report published ...

#63. Biogen (BIIB) | Historical & Forecast Data - Trefis

How Low Can Biogen Stock Go In A Market Crash? 2022-06-22. Biogen Stock Return Comparison. 2022-05-06.

#64. 2023-06-11 | NDAQ:NTLA | Press Release - Stockhouse

(NASDAQ:NTLA), a leading clinical-stage genome editing company focused on developing potentially curative therapeutics leveraging CRISPR-based ...

#65. Analyst Forecast For Intellia Therapeutics Inc. (NASDAQ: NTLA)

The trading price of Intellia Therapeutics Inc. (NASDAQ:NTLA) floating higher at last check on Monday, June 12, closing at $44.35, ...

#66. Intellia Therapeutics - NTLA - Stock Price Today - Zacks

Each of the company logos represented herein are trademarks of Microsoft Corporation; Dow Jones & Company; Nasdaq, Inc.; Forbes Media, LLC; Investor's Business ...

#67. Intellia touting possible 'functional cure' for HAE with gene ...

based Intellia (NASDAQ:NTLA) closed June 12 at $43.61, up 37 cents. ... positioning of NTLA-2002 among the lengthy roster of HAE drugs on ...

#68. Intellia Therapeutics (NASDAQ:NTLA) Shares Gap Up to $43.36

(NASDAQ:NTLA – Get Rating)'s share price gapped up prior to trading on Friday . The stock had previously closed at $43.36, but opened at $44.61.

#69. Summary - NTLA - NASDAQ - Weiss Ratings

The Weiss investment rating of Intellia Therapeutics, Inc. (NASDAQ: NTLA) is D-.

#70. Intellia Therapeutics (NTLA) PT Lowered to $107 at Chardan ...

Chardan Capital Markets analyst Geulah Livshits lowered the price target on Intellia Therapeutics (NASDAQ: NTLA) to $107.00 (from $111.00) ...

#71. Intellia Therapeutics Announces Retirement of Jean-François ...

CAMBRIDGE, Mass., June 05, 2023 (GLOBE NEWSWIRE) -- Intellia Therapeutics, Inc. (NASDAQ:NTLA), a leading clinical-stage genome editing ...

#72. Analyst Maintains Buy Rating on Intellia Therapeutics with ...

... Bank of America Securities analyst, Greg Harrison, announced that he has maintained a Buy rating on Intellia Therapeutics (NASDAQ:NTLA)

#73. NTLA-2002 Wins - YouTube

NTLA -2002 Wins. Hassan & Investing. Hassan & Investing ... Managing Stock Market Risk. MarketChameleon.com. MarketChameleon.com.

#74. meta materials special dividend - Agenda Bahnindustrie Frauen

Nasdaq With no reserves and virtually no production, ... BNGO, CRSP and NTLA Stocks, The Countdown to Destruction Has Already Begun for ...

#75. Inventiva stock climbs on delayed data from liver disease trial

Inventiva aims for $90M Nasdaq IPO after positive phase 2 ... The gene editing company has provided a bit more data on NTLA-2002, its second candidate to ...

#76. CRISPR and RNAi Systems: Nanobiotechnology Approaches to ...

Intellia Therapeutics, Inc. is a publicly traded company, trading on NASDAQ under the symbol “NTLA.” Information source: Caribou Biosciences (2020).